"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
Clinical trial NCT02452151 · UNKNOWN
Trial details
- NCT number
- NCT02452151
- Sponsor
- Onze Lieve Vrouwe Gasthuis
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-08-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.